Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 190
Selected: 0
NCT IDTitle
NCT02525068A Study of Enzalutamide in Combination With AZD5363 in Patients With mCRPC
NCT04985266A Trial of Early Detection of Molecular Relapse With Circulating Tumour DNA Tracking and Treatment With Palbociclib Plus Fulvestrant Versus Standard Endocrine Therapy in Patients With ER Positive HER2 Negative Breast Cancer
NCT02705846Analysing Outcomes After Prostate Cancer Diagnosis and Treatment in Carriers of Rare Germline Mutations
NCT00053092Combination Chemotherapy With or Without Rituximab in Treating Patients With Mantle Cell Lymphoma
NCT00005586Leucovorin and Fluorouracil Compared With Observation in Treating Patients With Colorectal Cancer That Has Been Surgically Removed
NCT02429427European Celecoxib Trial in Primary Breast Cancer
NCT01216800Intensity-Modulated Radiation Therapy or 3-Dimensional Conformal Radiation Therapy in Decreasing Hearing Loss in Patients Who Have Undergone Surgery for Parotid Tumors
NCT01658930Radical Versus Simple Hysterectomy and Pelvic Node Dissection With Low-risk Early Stage Cervical Cancer
NCT05082259ASTEROID: A Trial of ASTX660 in Combination With Pembrolizumab
NCT01693822A Phase II Study of Axitinib in Patients With Metastatic Renal Cell Cancer Unsuitable for Nephrectomy
NCT02819752PEmbrolizumab Combined With Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck
NCT02338622Trial of Olaparib in Combination With AZD5363 (ComPAKT)
NCT02338310Trial of Perioperative Endocrine Therapy - Individualising Care
NCT03145961A Trial Using ctDNA Blood Tests to Detect Cancer Cells After Standard Treatment to Trigger Additional Treatment in Early Stage Triple Negative Breast Cancer Patients
NCT02447549Study of Tumour Focused Radiotherapy for Bladder Cancer
NCT07002320Investigating SX-682 in Combination With Apalutamide in Metastatic Castration-resistant Prostate Cancer
NCT00959023Study of Blood and Tumor Samples From Men With an Inherited Risk of Prostate Cancer
NCT01964677MR-HIFU for Bone Metastases
NCT03621332HRQoL in Advanced Soft Tissue Sarcoma Patients Treated With Chemotherapy.
NCT07741929Patient and Provider Perspectives on Genetic Risk Profiling
NCT02541266Imaging in Clinical Trials - a Questionnaire Study to Assess Impact of Imaging Regimes on Patient Participation
NCT01567137MR Characterisation/Localisation of Breast Cancer
NCT03809377Transcriptional Responses as an Indicator of Individualised Responses to Radiation Effects (RTGene 2)
NCT03740893PHOENIX DDR/Anti-PD-L1 Trial: A Pre-surgical Window of Opportunity and Post-surgical Adjuvant Biomarker Study of DNA Damage Response Inhibition With or Without Anti-PD-L1 Immunotherapy in Patients With Neoadjuvant Treatment Resistant Residual Triple Negative Breast Cancer
NCT00253409Combination Chemotherapy With or Without Surgery and Radiation Therapy in Treating Patients With Mesothelioma That Can Be Removed By Surgery
NCT02437227Dose Escalation Study With Expansion to Evaluate Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of CCT3833
NCT00787514FR in Stored Plasma
NCT05810467The Active Surveillance Study
NCT03158922The BARCODE 1 Pilot Study
NCT07372885GRanulocyte Augmented Cord Blood Transplantation for Poor Risk leukaEmia
NCT01006564Multifunctional Magnetic Resonance (MR) for Radiotherapy Planning in Prostate Cancer
NCT02380027PRostate Evaluation for Clinically Important Disease: Sampling Using Image-guidance Or Not?
NCT00532727Triple Negative Breast Cancer Trial
NCT073912155G-PEARL: Paxalisib in Malignant Brain Tumours
NCT03592550The eValuation of Image Guidance of Stereotactic Body Radiotherapy Using Ultrasound: Assessment in Liver
NCT05097274The GENPET Study - An Imaging Study of FCH-PET-CT in Men With Prostate Cancer and a DNA Repair Gene Mutation.
NCT01332968A Study of Obinutuzumab (RO5072759) Plus Chemotherapy in Comparison With Rituximab Plus Chemotherapy Followed by Obinutuzumab or Rituximab Maintenance in Patients With Untreated Advanced Indolent Non-Hodgkin's Lymphoma (GALLIUM)
NCT066302605G-RUBY: Avutometinib and Defactinib in Malignant Brain Tumours
NCT00286117ITA - Clinical Study Comparing ARIMIDEX™ With NOLVADEX™ in Women With Breast Cancer Treated With NOLVADEX for at Least 2 Years
NCT02407509Phase I Trial of VS-6766 Alone and in Combination With Everolimus
NCT04584853PreOperative Endocrine Therapy for Individualised Care With Abemaciclib
NCT02955082The BARCODE 2 Study - The Use of Genetic Profiling to Guide Prostate Cancer Treatment
NCT03506997Trial of Pembrolizumab in Metastatic Castration Resistant Prostate Cancer
NCT00079248Hormone Replacement Therapy in Relieving Menopausal Symptoms in Postmenopausal Women With Previous Stage I or Stage II Breast Cancer
NCT01810757Study of Weekly Radiotherapy for Bladder Cancer
NCT00997464An Exploration of Genetic Testing for Prostate Cancer Susceptibility
NCT02759783Conventional Care Versus Radioablation (Stereotactic Body Radiotherapy) for Extracranial Oligometastases
NCT03466034The Role of Hypoxia as a Selective Pressure for TP53 Mutations
NCT06409221VISION: Triple Negative Breast Cancer Sample and Clinical Data Acquisition Study
NCT00814567Radiation Therapy in Women With Low Risk Early-Stage Breast Cancer Who Have Undergone Breast Conservation Surgery